Skip to main content

Table 1 Demographical and clinical characteristics of the study participants

From: Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD)

Characteristics

Classification

Value

Gender

female, male, n (%)

25 (56.8), 19 (43.2)

Age in years

mean (SD)

57.3 (± 15.3)

Type of onset

spinal, bulbar, n (%)

42 (95.5), 2 (4.5)

Disease duration (months)

mean (SD)

58.4 (± 45)

ALS Functional Rating Scale revised

mean (SD)

23.0 (± 9.2)

Presence of cognitive impairment

n (%)

3 (6.8)

  1. n Number of patients; SD standard deviation